ANAVEX LIFE SCIENCES CORP. Shares of Common Stock (par value $0.001 per share) Amended and Restated Sales AgreementSales Agreement • May 1st, 2020 • Anavex Life Sciences Corp. • Services-commercial physical & biological research • New York
Reference is made to the Controlled Equity OfferingSM Sales Agreement, dated as of July 6, 2018 (the “Original Agreement”), by and between Anavex Life Sciences Corp., a Nevada corporation (the “Company”) and Cantor Fitzgerald & Co. (the “Cantor”), pursuant to which the Company proposed to issue and sell through the Cantor, from time to time during the term of the Original Agreement, on the terms and subject to the conditions set forth in the Original Agreement, shares of common stock of the Company, par value $0.001 per share. The Company, Cantor and SVB Leerink LLC (together with Cantor, collectively, the “Agents”, and each individually an “Agent”) wish to amend and restate the Original Agreement in its entirety as provided hereby.
